
Hannah Kuchler
Global Pharmaceuticals Correspondent at Financial Times
Global pharma editor @FT, leading science and pharma team. Emmy-nominated, Loeb winner. Previously NY, SF, HK.
Articles
-
4 days ago |
ft.com | Oliver Barnes |Hannah Kuchler
UK medical robotics group CMR Surgical has put itself up for sale, seeking a valuation of as much as $4bn as the company plots its launch...
-
1 week ago |
ft.com | Hannah Kuchler
Swiss pharmaceutical company Roche is planning to move a new antibiotic into late stage clinical trials after early studies showed it had...
-
1 week ago |
ft.com | Hannah Kuchler |Richard Milne
When Lars Fruergaard Jørgensen came down the grand circular staircase at Novo Nordisk’s headquarters last week, employees gathered to...
-
2 weeks ago |
expansion.com | Peter Foster |Hannah Kuchler
-
2 weeks ago |
ft.com | Peter Foster |Hannah Kuchler |Sylvia Pfeifer |Kana Inagaki |Andy Bounds
Donald Trump’s threat to impose a 50 per cent tariff on all exports from the EU would deliver a hammer blow to key manufacturing sectors,...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 19K
- Tweets
- 2K
- DMs Open
- Yes

RT @AnnaSophieGross: NEW: AstraZeneca has ditched plans to build new vaccine manufacturing plant in Merseyside, less than a year after it w…

Scoop: AstraZeneca ditches plans to invest in a vaccine manufacturing plant in Speke. With @AnnaSophieGross https://t.co/kg8kvJlzkV

RT @ClaerB: There are high hopes for #bonusseason in the City this year - but how does yours measure up? Early entries to the FT's Bonus Su…